Poly-L-proline type II peptide mimics as probes of the active site occupancy requirements of cGMP-dependent protein kinase

Journal of Peptide Research

Volumn 66, Issue 4, 2005, Pages 151-159

  Zhang, R ^a   Nicki, C K ^a   Marnai, A ^a   Flemer, S ^a   Natarajan, A ^a   Dostmann, W R ^a   Madalengoitia, J S ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Peptide mimics; PKG; Poly L proline; Protein kinase

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 2; PEPTIDE; PROLINE;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROCESSING; RECEPTOR BINDING; RECEPTOR OCCUPANCY; X RAY CRYSTALLOGRAPHY;

CATALYTIC DOMAIN; CYCLIC GMP-DEPENDENT PROTEIN KINASES; MOLECULAR PROBES; PEPTIDES; PROTEIN STRUCTURE, TERTIARY;

EID: 25144436860     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2005.00280.x     Document Type: Article

References (32)

1. Cantley, L.C. & Songyang, Z. (1997) Specificity in protein-tyrosine kinase signaling. Adv. Second Messenger Phosphoprotein Res. 51, 41-48.
2. Dostmann, W.R., Nicki, C., Thiel, S., Tsigelny, I., Frank, R. & Tegge, W. (1999) Delineation of selective cyclic GMP-dependent protein kinase Iα substrate and inhibitor peptides based on combinatorial peptide libraries on paper. J. Pharmacol. Ther. 82, 373-387.
3. Dostmann, W.R., Taylor, M.S., Nicki, C.K., Brayden, J.E. & Frank, R.T.W.J. (2000) Highly specific, membrane-permanent peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. PIOC. Natl Acad. Sci. U S A 97, 14772-14777.
4. Nishikawa, K., Toker, A., Johannes, F.J., Songyang, Z. & Cantley, L.C. (1997) Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272, 952-960.
5. Obata, T., Yaffe, M.B., Leparc, G.G., Piro, E.T., Maegawa, H., Kashiwagi, A., Kikkawa, R. & Cantley, L.C. (2000) Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275, 36108-36115.
6. Ruzzene, M., Songyang, Z., Marin, O., Donella-Deana, A., Brunati, A.M., Guerra, B., Agostinis, P., Cantley, L.C. & Pinna, L.A. (1997) Sequence specificity of C-terminal Src kinase (CSK) - a comparison with Src-related kinases c-Fgr and Lyn. Eur. J. Biochem. 246, 433-439.
7. Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M.F., Piwnica-Worms, H. & Cantley, L.C. (1994) Use of an oriented peptide library to determine the optimal substrates of protein kinases. Cuir. Biol. 4, 973-982.
8. Songyang, Z., Lu, K.P., Kwon, Y.T., Tsai, L.H., Filhol, O., Cochet, C., Brickey, D.A., Soderling, T.R., Bartleson, C., Graves, D.J., DeMaggio, A.J., Hoekstra, M.F., Blenis, J., Hunter, T. & Cantley, L.C. (1996) A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16, 6486-6493.
9. Songyang, Z. & Cantley, L.C. (1998) The use of peptide library for the determination of kinase peptide substrates. Methods Mol. Biol. 87, 87-98.
10. Lee, K.H., Olson, G.L., Bolin, D.R., Benowitz, A.B., Sprengler, P.A., Smith, A.B. III, Hirschmann, R.F. a Wiley, D.C. (2000) The crystal structure of a pyrrolinone-peptide hybrid ligand bound to the human class II MHC protein HLA-DR1. J. Am. Chem. Soc. 122, 8370-8375.
11. Smith, A.B. III, Hirschmann, R.F., Pasternak, A., Guzman, M.C., Yokoyama, A., Sprengler, P.A., Darke, P.L., Emini, E. & Schleif, W.A. (1995) Pyrrolinone-based HIV protease inhibitors, design, synthesis, and antiviral activity: evidence for improved transport. J. Am. Chem. Soc. 117, 11113-11123.
12. Smith, A.B. III, Hirschmann, R.F., Pasternak, A., Yao, W., Sprengler, P.A., Holloway, M.K., Kuo, L.C., Chen, Z., Darke, P.L. & Schleif, W.A. (1997) An orally bioavailable pyrrolinone inhibitor of HIV-1 protease: computational analysis and X-ray crystal structure of the enzyme complex. J. Med. Chem. 40, 2440-2444.
13. Smith, A.B. III, Benowitz, A.B., Guzman, M.C., Sprengler, P.A., Hirschmann, R.F., Schweiger, E.J., Bolin, D.R., Nagy, Z., Campbell, R.M., Cox, D.C. & Olson, G.L. (1998) Design, synthesis, and evaluation of a pyrrolinone-peptide hybrid ligand for the class II MHC protein HLA-DR1. J. Am. Chem. Soc. 120, 12704-12705.
14. Smith, A.B., Cantin, L.D., Pasternak, A., Guise-Zawacki, L., Yao, W., Charnley, A.K., Barbosa, J., Sprengeler, P.A., Hirschmann, R., Munshi, S., Olsen, D.B., Schleif, W.A. & Kuo, L.C. (2003) Design, synthesis, and biological evaluation of monopyrrolinine-based HIV-1 protease inhibitors. J. Med. Chem. 46, 1831-1844.
15. 1 antagonist. J. Med. Chem. 45, 5353-5357.
16. Fisher, M.J., Gunn, B., Harms, C.S., Kline, A.D., Mullaney, J.T., Nunes, A., Scarborough, R.M., Arfsten, A.E., Skelton, M.A., Um, S.L., Utterback, B.G. & Jakubowski, J.A. (1997) Non-peptide RGD surrogates which mimic a Gly-Asp beta-Turn: potent antagonists of platelet glycoprotein Ilb-IIIa. J. Med. Chem. 40, 2085-2101.
17. Fisher, M.J., Giese, U., Harms, C.S., Kinnick, M.D., Lindstrom, T.D., McCowan, J.R., Mest, H.J., Morin, J.M., Mullaney, J.T., Paal, M., Rapp, A., Ruhter, G., Ruterbories, K.J., Sail, D.J., Scarborough, R.M., Schotten, T., Stenzel, W., Towner, R.D., Um, S.L., Utterback, B.G., Wyss, V.L. & Jakubowski, J.A. (2,000) Fused bicyclic Gly-Asp beta-turn mimics with potent affinity for GPIIb-IIa. Exploration of the arginine isostere. Bioorg. Med. Chem. Lett. 10, 385-389.
18. Bourguet, E., Baneres, J.L., Parello, J., Lusinchi, X., Girard, J.P. & Vidal, J.P. (2003) Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam. Bioorg. Med. Chem. Lett. 13, 1561-1564.
19. Knighton, D.R., Zheng, J., Ten Eyck, L.F., Xuong, N.H., Taylor, S.S. & Sowadski, J.M. (1991) Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 2,53, 414-42, 0.
20. Brown, N.R., Noble, M.E., Endicott, J.A. & Johnson, L.N. (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1, 438-443.
21. Lowe, E.D., Noble, M.E., Skamnaki, V.T., Oikonomakos, N.G., Owen, D.J. & Johnson, L.N. (1997) The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J. 16, 6646-6658.
22. Parang, K., Till, J.H., Ablooglu, AJ., Kohanski, R.A., Hubbard, S.R. & Cole, P.A. (2001) Mechanism-based design of a protein kinase inhibitor. Nat. Struct. Biol. 8, 16-18.
23. Erickson, A.K., Payne, D.M., Martino, P.A., Rossomando, A.J., Shabanowitz, J., Weber, M.J., Hunt, D.F. a Sturgill, T.W. (1990) Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase. J. Biol. Chem. 265, 19728-19735.
24. Chan, K.F., Stoner, G.L., Hashim, G.A. & Huang, K.P. (1986) Substrate specificity of rat brain calcium-activated and phospholipid dependent protein kinase. Biochem. Biophys. Res. Commun. 134, 1358-1364.
25. Zhang, R. & Madalengoitia, J.S. (1996) Conformational stability of proline oligomers. Tetrahedron Lett. 37, 6235-6238.
26. Zhang, R., Brownewell, F.E. & Madalengoitia, J.S. (1998) A(1,3) like strain as a key conformational control element in the design of poly-L-proline type II peptide mimics. J. Am. Chem. Soc. 120, 3894-3902.
27. Zhang, R. & Madalengoitia, J.S. (1999) Design, synthesis and evaluation of poly-L-proline type II peptide mimics based on the 3-aza-bicyclo[3.i.o]hexane system. J. Org. Chem. 64, 330-331.
28. Marnai, A., Zhang, R., Natarajan, A. & Madalengoitia, J.S. (2001) Poly-L-proline type II peptide mimics based on the 3-aza-bicyclo[3.1.0]hexane system. J. Org. Chem. 66, 455-460.
29. Grathwohl, C. & Wuthrich, K. (1976) The X-Pro peptide bond as an NMR probe for conformational studies of flexible linear peptides. Biopolymers 15, 2025-2041.
30. Zhang, R., Marnai, A. & Madalengoitia, J.S. (1999) Cyclopropanation reactions of pyroglutamic acid-derived synthons with alkylidene transfer reagents. J. Org. Chem. 64, 547-555.
31. Yajima, H., Fujii, N., Funakoshi, N., Watanabe, T., Murayama, E. & Otaka, A. (1998) A new strategy for the chemical synthesis of peptides. Tetrahedron 44, 805-819.
32. Taylor, M.S., Okwuchukwuasanya, C., Nicki, C.K., Brayden, J.E. & Dostmann, W.R.G. (2004) Unique inhibitory properties of the cell-permeable cGMP-dependent protein kinase inhibitor DT-2 reveal a novel mechanism of vasoregulation. Mol Pharm. 65, 1111-1119.